Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Motor Control|December 7, 2018
An Oculus Rift Assessment of Dynamic Balance by Head Mobility in a Virtual Park Scene: A Pilot StudyAnat V Lubetzky, Bryan D Hujsak, Gene Fu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2009
Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapyGene-Fu F Liu, Qifeng Yang, Bruce G Haffty, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|December 4, 2018
Control Mechanisms of Static and Dynamic Balance in Adults With and Without Vestibular Dysfunction in Oculus Virtual EnvironmentsAnat V Lubetzky, Bryan D Hujsak, Jennifer L Kelly, et al.
Plos One|January 14, 2014
Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated versus three-dimensional conformal radiotherapyGene-Fu F Liu, Ryan J Bair, Eric Bair, et al.
Journal of Oral & Maxillofacial Research|January 15, 2014
Animal models to study the mutational landscape for oral cavity and oropharyngeal cancersMichael T Spiotto, Matthew Pytynia, Gene-Fu F Liu, et al.
Disability and Rehabilitation. Assistive Technology|May 19, 2020
Contextual sensory integration training via head mounted display for individuals with vestibular disorders: a feasibility studyAnat V Lubetzky, Jennifer Kelly, Zhu Wang, et al.
Journal of Vestibular Research : Equilibrium & Orientation|March 13, 2023
Decrease in head sway as a measure of sensory integration following vestibular rehabilitation: A randomized controlled trialAnat V Lubetzky, Daphna Harel, Santosh Krishnamoorthy, et al.
Journal of Neuroengineering and Rehabilitation|August 11, 2023
Contextual sensory integration training vs. traditional vestibular rehabilitation: a pilot randomized controlled trialJennifer Kelly, Daphna Harel, Santosh Krishnamoorthy, et al.
Cancer|October 15, 2013
Racial parities in outcomes after radiotherapy for head and neck cancerGene-Fu F Liu, Mark C Ranck, Abhishek A Solanki, et al.
Molecular Cancer Therapeutics|February 23, 2018
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung CancersSean P Pitroda, Melinda E Stack, Gene-Fu Liu, et al.
Pageof 2